Controlled Clinical Trial to Evaluate the Safety and Efficacy of Stereotactical Photodynamic Therapy With 5-aminolevulinic Acid (Gliolan) in Recurrent Glioblastoma
Latest Information Update: 22 Dec 2022
At a glance
- Drugs Aminolevulinic acid (Primary)
- Indications Glioblastoma
- Focus Therapeutic Use
- Acronyms NOA11
- 14 Apr 2021 Planned End Date changed from 1 Mar 2026 to 1 Apr 2026.
- 14 Apr 2021 Planned primary completion date changed from 1 Mar 2026 to 1 Apr 2026.
- 10 Mar 2021 Planned End Date changed from 1 Nov 2025 to 1 Mar 2026.